Stock & Company Details
Context Therapeutics Inc $CNTX
Price:
N/A
N/A
92M
$38M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.79
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Services
CNTX technical indicators
Latest Context Therapeutics Inc (CNTX) indicator readings as of 2026-08-28.
CNTX's 14-day RSI is 29.1, in oversold territory. At $0.38 it is trading 76.8% below its 200-day moving average of $1.66, and below its 50-day average of $0.57. Price sits near the lower Bollinger Band ($0.36 to $0.64). ADX reads 33.1, indicating a trending market.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Context Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to improving the lives of women living with cancer. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer.
Finance Bot
Ask your questions
Start by typing a question below.
